Tumor Cell-Specific Delivery of Paclitaxel Using a Self-assembled Matrix Metalloprotease 2-sensitive Nanocarrier

Lin Zhu, Anton Taigind, and Vladimir P Torchilin
Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115

VEW WEBCAST

Summary
To increase the solubility, bioavailablity and targetability of the water insoluble drug, paclitaxel (PTX), we synthesized a novel amphiphilic PEG-PTX conjugate with the matrix metalloprotease 2-sensitive peptide link between PEG and PTX, which was incorporated into novel nanocarrier system. Our system is a self-assembled micellar nanocarrier (Fig.1) containing three amphiphilic PEGbased conjugates, PEG(2000)-peptide- PTX, PEG(1000)-PE, and TATp-PEG(1000)- DOPE. Compared to conventional micellar drug delivery systems, this design ensures: i) a high drug loading efficiency, ii) an increased micelle stability, iii) an increased drug targetability, and iv) an enhanced drug internalization by the tumor cells.

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link